FREMONT, Calif.-– WaferGen Bio-systems, Inc. (OTCQB: WGBS) announced today a commercial partnership with Molecular Pathology Laboratory Network, Inc. (MPLN) with the goal of developing Next-Generation sequencing (NGS) based clinical tests. “One of the key challenges in developing clinical grade targeted NGS panels is achieving complete coverage of the required genes. Based on my experience, WaferGen’s […]

OMAHA, Neb. — Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced that the European Patent Office has issued a new patent, European Patent No. 21833798, covering one of its COLD-PCR family of DNA amplification technologies. […]

Männedorf, Switzerland — The Tecan Group (SIX Swiss Exchange: TECN) today announced the acquisition of IBL International as an important strategic step to support Tecan’s evolution into a solutions business with a higher share of recurring revenues. IBL International is a leading company in the field of microtiter plate based immunoassays with one of the […]

Männedorf, Switzerland — The Tecan Group (SIX Swiss Exchange: TECN) today announced the acquisition of IBL International as an important strategic step to support Tecan’s evolution into a solutions business with a higher share of recurring revenues. IBL International is a leading company in the field of microtiter plate based immunoassays with one of the […]

NEW YORK, NY — Enzo Biochem, Inc. (NYSE: ENZ) announced today that U.S. District Judge Leonard P. Stark has established August 18th as the date for a patent claim construction hearing, also called a Markman hearing, involving Enzo Life Science’s U.S. Patents Nos. 6,992,180, 7,064,197, and 8,097,405. The hearing will be held in Delaware District […]

SUNNYVALE, Calif.– With the recent completion of a record shipment of 774 GeneXpert systems to a single country in one quarter, Cepheid (Nasdaq: CPHD) today applauded groundbreaking tuberculosis programs in China where more than a million new cases of tuberculosis (TB) are reported each year. Combined with systems placed previously, the second quarter placements bring […]

Hilden, Germany, and London, U.K. -– QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced a collaboration agreement with AstraZeneca PLC (LSE, NYSE and OMX: AZN) for the co-development and commercialization of a liquid biopsy-based companion diagnostic to be paired with IRESSA, AstraZeneca’s targeted therapy for non-small cell lung cancer (NSCLC). The project builds on […]

BALTIMORE — BD Diagnostics, a segment of BD (Becton, Dickinson and Company), (NYSE: BDX) announced today it has received 510(k) clearance from the U.S. Food and Drug Administration for the BD ProbeTec™ Chlamydia trachomatis (CT) Qx Amplified DNA Assay and the BD ProbeTec™ Neisseria gonorrhoeae (GC) Qx Amplified DNA Assay on the BD Viper™ LT […]

Baltimore, MD — BD Diagnostics, a segment of BD (Becton, Dickinson and Company), announced today that it has achieved CE/IVD marking for the BD ProbeTec™ Chlamydia trachomatis (CT) Qx Amplified DNA Assay and the BD ProbeTec™ Neisseria gonorrhoeae (GC) Qx Amplified DNA Assay on the BD Viper™ LT System. The BD Viper LT System is […]

Hercules, CA — – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostics products, announced today that Joel McComb has been appointed to its Board of Directors. Mr. McComb has 25 years of life science and diagnostics business experience. Since mid-2010 he founded three technology companies in […]